Compare Pfizer with Unichem Lab - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs UNICHEM LAB - Comparison Results

PFIZER     Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER UNICHEM LAB PFIZER/
UNICHEM LAB
 
P/E (TTM) x 48.3 -47.3 - View Chart
P/BV x 8.0 1.2 691.1% View Chart
Dividend Yield % 0.4 1.2 35.7%  

Financials

 PFIZER   UNICHEM LAB
EQUITY SHARE DATA
    PFIZER
Mar-19
UNICHEM LAB
Mar-19
PFIZER/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs3,840292 1,315.1%   
Low Rs2,080182 1,142.9%   
Sales per share (Unadj.) Rs455.0167.7 271.4%  
Earnings per share (Unadj.) Rs93.8-3.6 -2,583.0%  
Cash flow per share (Unadj.) Rs109.45.9 1,841.0%  
Dividends per share (Unadj.) Rs22.504.00 562.5%  
Dividend yield (eoy) %0.81.7 45.0%  
Book value per share (Unadj.) Rs658.2372.3 176.8%  
Shares outstanding (eoy) m45.7570.38 65.0%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x6.51.4 460.3%   
Avg P/E ratio x31.6-65.3 -48.4%  
P/CF ratio (eoy) x27.139.9 67.8%  
Price / Book Value ratio x4.50.6 706.3%  
Dividend payout %24.0-110.2 -21.8%   
Avg Mkt Cap Rs m135,42016,680 811.9%   
No. of employees `0002.62.6 101.1%   
Total wages/salary Rs m3,2382,393 135.3%   
Avg. sales/employee Rs Th7,911.44,535.2 174.4%   
Avg. wages/employee Rs Th1,230.9919.8 133.8%   
Avg. net profit/employee Rs Th1,630.7-98.2 -1,660.6%   
INCOME DATA
Net Sales Rs m20,81511,801 176.4%  
Other income Rs m1,674984 170.1%   
Total revenues Rs m22,48912,785 175.9%   
Gross profit Rs m5,712-835 -684.2%  
Depreciation Rs m714674 106.0%   
Interest Rs m7375 96.9%   
Profit before tax Rs m6,599-600 -1,100.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,309-343 -672.1%   
Profit after tax Rs m4,291-256 -1,679.1%  
Gross profit margin %27.4-7.1 -387.9%  
Effective tax rate %35.057.3 61.1%   
Net profit margin %20.6-2.2 -951.9%  
BALANCE SHEET DATA
Current assets Rs m27,16720,384 133.3%   
Current liabilities Rs m8,9175,029 177.3%   
Net working cap to sales %87.7130.1 67.4%  
Current ratio x3.04.1 75.2%  
Inventory Days Days68105 64.7%  
Debtors Days Days30135 22.3%  
Net fixed assets Rs m8,8629,023 98.2%   
Share capital Rs m458141 324.9%   
"Free" reserves Rs m29,65626,058 113.8%   
Net worth Rs m30,11326,199 114.9%   
Long term debt Rs m250-   
Total assets Rs m39,40031,496 125.1%  
Interest coverage x91.5-7.0 -1,312.2%   
Debt to equity ratio x00-  
Sales to assets ratio x0.50.4 141.0%   
Return on assets %11.1-0.6 -1,934.3%  
Return on equity %14.2-1.0 -1,460.8%  
Return on capital %22.1-2.0 -1,107.3%  
Exports to sales %069.4 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA8,188 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m4288,188 5.2%   
Fx outflow Rs m786596 131.9%   
Net fx Rs m-3587,592 -4.7%   
CASH FLOW
From Operations Rs m978-3,278 -29.8%  
From Investments Rs m351-2,860 -12.3%  
From Financial Activity Rs m-1,099-24 4,539.3%  
Net Cashflow Rs m231-4,690 -4.9%  

Share Holding

Indian Promoters % 0.0 50.1 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 15.1 49.7%  
FIIs % 4.9 3.0 163.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 31.7 74.8%  
Shareholders   85,207 20,176 422.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   ORCHID PHARMA  WYETH  TORRENT PHARMA  SUVEN LIFE SCIENCES  DR. REDDYS LAB  

Compare PFIZER With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty End Flat; Asian Paints, UPL & ITC Among Top Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views on News

PFIZER Announces Quarterly Results (3QFY21); Net Profit Up 1.6% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, PFIZER has posted a net profit of Rs 1 bn (up 1.6% YoY). Sales on the other hand came in at Rs 6 bn (up 10.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (2QFY21); Net Profit Down 14.8% (Quarterly Result Update)

Nov 4, 2020 | Updated on Nov 4, 2020

For the quarter ended September 2020, PFIZER has posted a net profit of Rs 1 bn (down 14.8% YoY). Sales on the other hand came in at Rs 6 bn (up 5.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (1QFY21); Net Profit Up 10.3% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, PFIZER has posted a net profit of Rs 1 bn (up 10.3% YoY). Sales on the other hand came in at Rs 5 bn (down 5.4% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (3QFY20); Net Profit Up 5.4% (Quarterly Result Update)

Feb 19, 2020 | Updated on Feb 19, 2020

For the quarter ended December 2019, PFIZER has posted a net profit of Rs 1 bn (up 5.4% YoY). Sales on the other hand came in at Rs 5 bn (up 4.7% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (2QFY20); Net Profit Up 61.0% (Quarterly Result Update)

Oct 29, 2019 | Updated on Oct 29, 2019

For the quarter ended September 2019, PFIZER has posted a net profit of Rs 2 bn (up 61.0% YoY). Sales on the other hand came in at Rs 6 bn (up 9.1% YoY). Read on for a complete analysis of PFIZER's quarterly results.

More Views on News

Most Popular

My Secret to Find Breakthrough Stocks(Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

Are the Stock Markets Deaf to Covid Agony?(Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

The Worst Sector in the Market(Fast Profits Daily)

May 11, 2021

The worst sector in the stock market according to the charts.

The Key to Profit from India's EV Revolution(Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


May 14, 2021 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS